Hanx Biopharmaceuticals Relocates Hong Kong Principal Office to Lee Garden One

Bulletin Express
06/02

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. announced that, effective 2 June 2026, its principal place of business in Hong Kong has been relocated to Room 1918, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.

The company confirmed that its telephone number, email address and website remain unchanged following the move.

The announcement was authorised by the Board of Directors and signed by Chairman and Executive Director Dr. Zhang Faming on the date of the notice.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10